127 related articles for article (PubMed ID: 33977972)
1. Glycodendritic structures as DC-SIGN binders to inhibit viral infections.
Ramos-Soriano J; Rojo J
Chem Commun (Camb); 2021 May; 57(42):5111-5126. PubMed ID: 33977972
[TBL] [Abstract][Full Text] [Related]
2. Glycofullerenes inhibit viral infection.
Luczkowiak J; Muñoz A; Sánchez-Navarro M; Ribeiro-Viana R; Ginieis A; Illescas BM; Martín N; Delgado R; Rojo J
Biomacromolecules; 2013 Feb; 14(2):431-7. PubMed ID: 23281578
[TBL] [Abstract][Full Text] [Related]
3. A multivalent inhibitor of the DC-SIGN dependent uptake of HIV-1 and Dengue virus.
Varga N; Sutkeviciute I; Ribeiro-Viana R; Berzi A; Ramdasi R; Daghetti A; Vettoretti G; Amara A; Clerici M; Rojo J; Fieschi F; Bernardi A
Biomaterials; 2014 Apr; 35(13):4175-84. PubMed ID: 24508075
[TBL] [Abstract][Full Text] [Related]
4. Mannose hyperbranched dendritic polymers interact with clustered organization of DC-SIGN and inhibit gp120 binding.
Tabarani G; Reina JJ; Ebel C; Vivès C; Lortat-Jacob H; Rojo J; Fieschi F
FEBS Lett; 2006 May; 580(10):2402-8. PubMed ID: 16616922
[TBL] [Abstract][Full Text] [Related]
5. 1,2-Mannobioside mimic: synthesis, DC-SIGN interaction by NMR and docking, and antiviral activity.
Reina JJ; Sattin S; Invernizzi D; Mari S; Martínez-Prats L; Tabarani G; Fieschi F; Delgado R; Nieto PM; Rojo J; Bernardi A
ChemMedChem; 2007 Jul; 2(7):1030-6. PubMed ID: 17508368
[TBL] [Abstract][Full Text] [Related]
6. DC-SIGN, DC-SIGNR and LSECtin: C-type lectins for infection.
Zhang F; Ren S; Zuo Y
Int Rev Immunol; 2014 Jan; 33(1):54-66. PubMed ID: 24156700
[TBL] [Abstract][Full Text] [Related]
7. Nonhydrolyzable C-disaccharides, a new class of DC-SIGN ligands.
Bertolotti B; Oroszová B; Sutkeviciute I; Kniežo L; Fieschi F; Parkan K; Lovyová Z; Kašáková M; Moravcová J
Carbohydr Res; 2016 Nov; 435():7-18. PubMed ID: 27676269
[TBL] [Abstract][Full Text] [Related]
8. 1D saturation transfer difference NMR experiments on living cells: the DC-SIGN/oligomannose interaction.
Mari S; Serrano-Gómez D; Cañada FJ; Corbí AL; Jiménez-Barbero J
Angew Chem Int Ed Engl; 2004 Dec; 44(2):296-8. PubMed ID: 15614901
[No Abstract] [Full Text] [Related]
9. DC-SIGN: a novel HIV receptor on DCs that mediates HIV-1 transmission.
Geijtenbeek TB; van Kooyk Y
Curr Top Microbiol Immunol; 2003; 276():31-54. PubMed ID: 12797442
[TBL] [Abstract][Full Text] [Related]
10. Selective targeting of dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN) with mannose-based glycomimetics: synthesis and interaction studies of bis(benzylamide) derivatives of a pseudomannobioside.
Varga N; Sutkeviciute I; Guzzi C; McGeagh J; Petit-Haertlein I; Gugliotta S; Weiser J; Angulo J; Fieschi F; Bernardi A
Chemistry; 2013 Apr; 19(15):4786-97. PubMed ID: 23417900
[TBL] [Abstract][Full Text] [Related]
11. Monovalent mannose-based DC-SIGN antagonists: targeting the hydrophobic groove of the receptor.
Tomašić T; Hajšek D; Švajger U; Luzar J; Obermajer N; Petit-Haertlein I; Fieschi F; Anderluh M
Eur J Med Chem; 2014 Mar; 75():308-26. PubMed ID: 24556146
[TBL] [Abstract][Full Text] [Related]
12. Antiviral activity of carbohydrate-binding agents and the role of DC-SIGN in dengue virus infection.
Alen MM; Kaptein SJ; De Burghgraeve T; Balzarini J; Neyts J; Schols D
Virology; 2009 Apr; 387(1):67-75. PubMed ID: 19264337
[TBL] [Abstract][Full Text] [Related]
13. Crucial role of the N-glycans on the viral E-envelope glycoprotein in DC-SIGN-mediated dengue virus infection.
Alen MM; Dallmeier K; Balzarini J; Neyts J; Schols D
Antiviral Res; 2012 Dec; 96(3):280-7. PubMed ID: 23124109
[TBL] [Abstract][Full Text] [Related]
14. Non-carbohydrate inhibitors of the lectin DC-SIGN.
Borrok MJ; Kiessling LL
J Am Chem Soc; 2007 Oct; 129(42):12780-5. PubMed ID: 17902657
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis reveals selective recognition of glycans by the dendritic cell receptors DC-SIGN and Langerin.
Holla A; Skerra A
Protein Eng Des Sel; 2011 Sep; 24(9):659-69. PubMed ID: 21540232
[TBL] [Abstract][Full Text] [Related]
16. Proteomic analysis of DC-SIGN on dendritic cells detects tetramers required for ligand binding but no association with CD4.
Bernhard OK; Lai J; Wilkinson J; Sheil MM; Cunningham AL
J Biol Chem; 2004 Dec; 279(50):51828-35. PubMed ID: 15385553
[TBL] [Abstract][Full Text] [Related]
17. DC-SIGN mediates binding of dendritic cells to authentic pseudo-LewisY glycolipids of Schistosoma mansoni cercariae, the first parasite-specific ligand of DC-SIGN.
Meyer S; van Liempt E; Imberty A; van Kooyk Y; Geyer H; Geyer R; van Die I
J Biol Chem; 2005 Nov; 280(45):37349-59. PubMed ID: 16155001
[TBL] [Abstract][Full Text] [Related]
18. Identification of the mycobacterial carbohydrate structure that binds the C-type lectins DC-SIGN, L-SIGN and SIGNR1.
Koppel EA; Ludwig IS; Hernandez MS; Lowary TL; Gadikota RR; Tuzikov AB; Vandenbroucke-Grauls CM; van Kooyk Y; Appelmelk BJ; Geijtenbeek TB
Immunobiology; 2004; 209(1-2):117-27. PubMed ID: 15481146
[TBL] [Abstract][Full Text] [Related]
19. Carbohydrate signaling by C-type lectin DC-SIGN affects NF-kappaB activity.
Gringhuis SI; Geijtenbeek TB
Methods Enzymol; 2010; 480():151-64. PubMed ID: 20816209
[TBL] [Abstract][Full Text] [Related]
20. Infection of dendritic cells (DCs), not DC-SIGN-mediated internalization of human immunodeficiency virus, is required for long-term transfer of virus to T cells.
Burleigh L; Lozach PY; Schiffer C; Staropoli I; Pezo V; Porrot F; Canque B; Virelizier JL; Arenzana-Seisdedos F; Amara A
J Virol; 2006 Mar; 80(6):2949-57. PubMed ID: 16501104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
